Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Offerings

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • News
  • Offerings
  • Trading Ideas

Nogin Shares Moving Higher, Co Announces Closing Of $22M Public Offering

By Happy Mohamed
April 6, 12:20 PM
Nogin, Inc. (NASDAQ:NOGN, NOGNW)))) ("Nogin" or the "Company"), a leading provider of innovative Commerce-as-a-Service (CaaS) technology and services, today announces the closing of its

NOGN

Read More
1 minute read
  • News
  • Offerings
  • Small Cap

Why Protagonist Therapeutics Shares Are Nosediving

By Henry Khederian
April 5, 10:28 AM
Protagonist Therapeutics Inc (NASDAQ: PTGX) shares are trading lower by 9.68% to $19.46 Wednesday morning after the company announced pricing of a $100 million public offering of shares of common stock. What Else?

PTGX

Read More
1 minute read
  • News
  • Offerings

Reported Late Tuesday April 4, Protagonist Therapeutics Announces Pricing Of $100M Public Offering Of 5M Shares Of Common Stock At A Price Of $20/Share

By Happy Mohamed
April 5, 12:38 AM
 Protagonist Therapeutics (NASDAQ:PTGX) ("Protagonist" or the "Company") today announced the pricing of its previously announced underwritten public offering of 5,000,000 shares of its common

PTGX

Read More
1 minute read
  • News
  • Offerings
  • Penny Stocks

Why Clearmind Medicine Shares Are Nosediving

By Henry Khederian
April 4, 11:52 AM
Clearmind Medicine Inc (NASDAQ: CMND) shares are trading lower by 60.1% to $0.57 Tuesday morning after the company announced a $3.5 million public offering priced at $0.78 per share. The offering is expected to close on April 6, subject to the satisfaction of customary closing conditions.

CMND

Read More
1 minute read
  • General
  • News
  • Offerings

Nogin Plummets Following $22M Equity Offering

By Shivani Kumaresan
April 4, 9:42 AM
Nogin Inc (NASDAQ:NOGN) has priced the public offering of 7.33 million shares of common stock and 7.33 million common…

NOGN

Read More
1 minute read
  • Movers
  • News
  • Offerings
  • Penny Stocks

Nogin Stock Is Tanking Today: What’s Going On?

By Adam Eckert
April 4, 9:15 AM
Shares of low-float Nogin Inc (NASDAQ: NOGN) are trading lower. The company announced a $22 million public offering on Tuesday.

NOGN

Read More
1 minute read
  • News
  • Offerings

Clearmind Medicine Announces Pricing Of $3.5M Public Offering Of 4,505,718 Common Shares And Pre-Funded Warrants At A Price Of $0.78/Share

By Happy Mohamed
April 4, 9:06 AM
Clearmind Medicine Inc. (NASDAQ:CMND) (CSE:CMND), (FSE: CWY) ("Clearmind"), a biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve major under-treated

CMND

Read More
1 minute read
  • News
  • Offerings

Nogin Announces Pricing Of $22M Public Offering Of 7,333,334 Shares Of Common Stock And Warrants At A Combined Price Of $3/Share

By Happy Mohamed
April 4, 8:37 AM
 Nogin, Inc. (NASDAQ:NOGN) ("Nogin" or the "Company"), a leading provider of innovative Commerce-as-a-Service (CaaS) technology and services, today announced the pricing of its

NOGN

Read More
1 minute read
  • News
  • Offerings
  • Penny Stocks

Why Palisade Bio (PALI) Stock Is Diving 30% Lower

By Henry Khederian
April 3, 9:55 AM
Palisade Bio Inc (NASDAQ: PALI) shares are trading lower by 31.82% to $2.40 after the company announced a $6 million registered direct offering and concurrent private placement priced above the market under Nasdaq rules.

PALI

Read More
2 minute read
  • News
  • Offerings

Transphorm Enters Into Agreements To Raise $9.3M From The Exercise Of Existing Warrants And A Private Placement Of Common Stock

By Happy Mohamed
April 3, 9:19 AM
Transphorm, Inc. (NASDAQ:TGAN) ("Transphorm" or the "Company"), a pioneer in and global supplier of high-reliability, high-performance gallium nitride (GaN) power conversion products, announced today

TGAN

Posts pagination

Previous 1 … 84 85 86 … 166 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service